Overview A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk Status: Recruiting Trial end date: 2025-12-01 Target enrollment: Participant gender: Summary A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk Phase: Phase 2 Details Lead Sponsor: Jing Jin, M.D.